Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Rangering i aksjer #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Aksjekurs
$0.2219522
Sist synkronisert: 2025-09-11
Markedsverdi
$1.10B
Endring (1 dag)
0.04%
Endring (1 år)
0.17%
Land
CN
Handel Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Historikk for aksjesplitt for Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Aksjen Hubei Biocause Pharmaceutical Co., Ltd. (symbol: 000627) har gjennomgått totalt 8 aksjesplitt.
Den nyeste splittelsen skjedde Apr 12, 2010.
Én 000627-aksje kjøpt før Dec 27, 1996 tilsvarer i dag 21.70959235632 000627-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
2010-04-12 37:20 x1.85 x21.70959235632
2005-11-09 33:25 x1.32 x11.7349147872
2002-06-12 23:20 x1.15 x8.89008696
2001-09-24 3:2 x1.5 x7.7305104
2001-05-23 59649:50000 x1.19298 x5.1536736
2000-05-16 6:5 x1.2 x4.32
1999-09-07 9:5 x1.8 x3.6
1996-12-27 2:1 x2 x2
Aksjesplitt for lignende selskaper eller konkurrenter